These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1907949)

  • 1. [The HBsAG negative, anti-HBc/anti-HBS positive patient].
    Blum HE; von Weizsäcker F
    Internist (Berl); 1991 May; 32(5):262-6. PubMed ID: 1907949
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of anti-HBc and IgM.anti-HBc].
    Chen BJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Apr; 10(2):104-9. PubMed ID: 2970316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
    Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
    Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
    Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
    Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-HBc IgM in HBsAg-negative chronic hepatitis].
    Rodríguez M; Pérez R; Sala P; Rodrigo L
    Med Clin (Barc); 1985 Jun; 85(5):209-10. PubMed ID: 4021640
    [No Abstract]   [Full Text] [Related]  

  • 9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of detecting HBV DNA with nested-PCR in the sera from patients with anti-HBs positive].
    Huang LH; Jiang YM; Huang ZH; Wu HY; Yang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):631-2. PubMed ID: 14572352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-transfusion viral hepatitis B and C and criteria of their differentiation].
    Tsybuliak SN; Gylka R
    Klin Med (Mosk); 1992; 70(3-4):42-4. PubMed ID: 1507846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and prognostic significance of anti-HBCAG IgM in hepatitis B and its outcomes].
    Fedorchenko SV
    Klin Med (Mosk); 1991 Apr; 69(4):66-8. PubMed ID: 1865655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inapparent "wild-type" and "e-minus variant" HBV infection in patients with HCV-related chronic hepatitis.
    Sardo MA; Rodinò G; Brancatelli S; Pernice M; Campo S; Squadrito G; Russo F; Raimondo G
    Liver; 1994 Oct; 14(5):241-4. PubMed ID: 7997082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
    Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
    HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presence of anti-HBc antibodies in Australia-antigen-negative hepatitis].
    Vargas V; Ruiz J; Esteban R; Pedreira JD; Hernandez JM; Guardia J; Bacardi R
    Nouv Presse Med; 1979 Nov; 8(45):3756. PubMed ID: 534241
    [No Abstract]   [Full Text] [Related]  

  • 19. [The frequency of HBsAg in plasma donors, and the incidence of anti HBs, anti HBc, anti HBe and anti HAV in HBsAg negative plasma donors in Zagreb (author's transl)].
    Grgicević D; Pistotnik M; Mikulicić V; Marchiotti I
    Lijec Vjesn; 1980 Sep; 102(9):475-7. PubMed ID: 6264240
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of HBV serological markers in patients with chronic hepatitis].
    Cichoz-Lach H; Słomka M; Daniluk J; Celiński K; Pokora J
    Pol Arch Med Wewn; 1992 Oct; 88(4):244-9. PubMed ID: 1488325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.